FA
FDx Advisors Portfolio holdings
AUM
$327M
1-Year Return
15.39%
This Quarter Return
+4.33%
1 Year Return
+15.39%
3 Year Return
+58.88%
5 Year Return
+87.77%
10 Year Return
+180.18%
AUM
$2.65B
AUM Growth
+$225M
(+9.3%)
Cap. Flow
+$139M
Cap. Flow
% of AUM
5.23%
Top 10 Holdings %
Top 10 Hldgs %
25.84%
Holding
813
New
111
Increased
425
Reduced
226
Closed
49
Top Buys
| 1 |
Amazon
AMZN
|
$46.9M |
| 2 |
Netflix
NFLX
|
$27.9M |
| 3 |
Salesforce
CRM
|
$13.5M |
| 4 |
Schwab US TIPS ETF
SCHP
|
$10.4M |
| 5 |
Microsoft
MSFT
|
$7.31M |
Top Sells
| 1 |
Dollar General
DG
|
$26M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$20.4M |
| 3 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
$11.7M |
| 4 |
Align Technology
ALGN
|
$8.42M |
| 5 |
PayPal
PYPL
|
$6.65M |
Sector Composition
| 1 | Technology | 22.33% |
| 2 | Healthcare | 12.86% |
| 3 | Financials | 11.1% |
| 4 | Communication Services | 10.47% |
| 5 | Consumer Discretionary | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Tyler Technologies
TYL
$24.2B
| $1.61M | 0.06% |
3,794
+268
| +8% | +$114K |
|
202
Grand Canyon Education
LOPE
$5.74B
| $1.6M | 0.06% |
14,949
+5,546
| +59% | +$594K |
|
203
Ameriprise Financial
AMP
$46.1B
| $1.56M | 0.06% |
6,699
-555
| -8% | -$129K |
|
204
Allegion
ALLE
$14.8B
| $1.55M | 0.06% |
12,371
+2,755
| +29% | +$346K |
|
205
Intellia Therapeutics
NTLA
$1.29B
| $1.55M | 0.06% |
19,363
-3,046
| -14% | -$244K |
|
206
Rio Tinto
RIO
$104B
| $1.54M | 0.06% |
19,854
+1,594
| +9% | +$124K |
|
207
Bio-Techne
TECH
$8.46B
| $1.53M | 0.06% |
16,052
+5,168
| +47% | +$494K |
|
208
Analog Devices
ADI
$122B
| $1.52M | 0.06% |
9,806
-1,218
| -11% | -$189K |
|
|
AZPN
209
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $1.5M | 0.06% |
10,364
+2,967
| +40% | +$428K |
|
210
KLA
KLAC
$119B
| $1.5M | 0.06% |
4,525
+47
| +1% | +$15.5K |
|
211
Pool Corp
POOL
$12.4B
| $1.49M | 0.06% |
4,328
+1,228
| +40% | +$424K |
|
212
Union Pacific
UNP
$131B
| $1.49M | 0.06% |
6,770
+406
| +6% | +$89.5K |
|
213
RB Global
RBA
$21.4B
| $1.49M | 0.06% |
25,402
+9,631
| +61% | +$564K |
|
214
Spotify
SPOT
$146B
| $1.49M | 0.06% |
5,544
+379
| +7% | +$102K |
|
215
Stryker
SYK
$150B
| $1.46M | 0.06% |
5,992
+413
| +7% | +$101K |
|
216
Exponent
EXPO
$3.61B
| $1.44M | 0.05% |
14,755
+4,359
| +42% | +$425K |
|
217
Dominion Energy
D
$49.7B
| $1.43M | 0.05% |
18,848
+4,484
| +31% | +$341K |
|
|
HZNP
218
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.43M | 0.05% |
15,552
+8,303
| +115% | +$764K |
|
219
CVS Health
CVS
$93.6B
| $1.42M | 0.05% |
18,859
+8,804
| +88% | +$662K |
|
220
Rollins
ROL
$27.4B
| $1.41M | 0.05% |
41,047
+7,706
| +23% | +$265K |
|
221
Monster Beverage
MNST
$61B
| $1.41M | 0.05% |
30,960
+388
| +1% | +$17.7K |
|
222
Regions Financial
RF
$24.1B
| $1.4M | 0.05% |
67,802
+19,745
| +41% | +$408K |
|
223
Enbridge
ENB
$105B
| $1.38M | 0.05% |
37,959
+6,968
| +22% | +$254K |
|
224
BlackLine
BL
$3.32B
| $1.37M | 0.05% |
12,671
+3,259
| +35% | +$353K |
|
225
Bristol-Myers Squibb
BMY
$96B
| $1.37M | 0.05% |
21,703
-12,843
| -37% | -$811K |
|